Trial Profile
Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy volunteers: a randomized, placebo-controlled, double-blind fMRI study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Caffeine (Primary) ; Methylphenidate (Primary) ; Modafinil (Primary)
- Indications Apnoea; Attention-deficit hyperactivity disorder; Narcolepsy
- Focus Therapeutic Use
- Acronyms MKM
- 01 Feb 2021 Results published in the Psychopharmacology
- 16 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2014 New trial record